Versant Venture Management, LLC
8 holdingsFiling period: 2026-06-30Current AUM: $114.0Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | GLUE | Monte Rosa Therapeutics, Inc. | 3.18M | $77.0M | $41.3M | 36.23% | -- | 2026-06-30 |
| 2 | IPSC | Century Therapeutics, Inc. | 12.17M | $29.8M | $24.1M | 21.12% | -- | 2026-06-30 |
| 3 | JBIO | Jade Biosciences, Inc. | 991.8K | $22.0M | $17.2M | 15.12% | -534,037 | 2026-06-30 |
| 4 | LENZ | Lenz Therapeutics, Inc. | 2.66M | $15.1M | $11.2M | 9.86% | -- | 2026-06-30 |
| 5 | CTNM | Contineum Therapeutics, Inc. | 542.6K | $8.9M | $7.5M | 6.58% | -- | 2026-06-30 |
| 6 | — | CRISPR Therapeutics AG | 148.8K | $8.1M | $8.1M | 7.12% | -- | 2026-06-30 |
| 7 | SKYE | Skye Bioscience, Inc. | 2.01M | $1.4M | $4.2M | 3.71% | -- | 2026-06-30 |
| 8 | OVAS | Tempest Therapeutics, Inc. | 269.8K | $299K | $299K | 0.26% | -- | 2026-06-30 |
← Scroll →